Thus, there are studies showing that α-MSH, used in the treatment of vitiligo, protects against H2O2-induced loss of dendrites in melanocytes through activation of the mTORC1 (mammalian target of rapamycin complex 1) pathway, which is inhibited by rapamycin [91]. This evidence concerns the gene STAMBP and vitiligo.